June 12 (Reuters) - German biotech firm BioNTech (22UAy.DE), opens new tab has agreed to acquire domestic peer CureVac (5CV.DE), opens new tab for about $1.25 billion worth of BioNTech shares, it said ...
BNT327/ PM8002, an investigational bispecific antibody combining PD-L1 checkpoint inhibition with VEGF-A neutralization being developed in collaboration with Biotheus: For more information, please ...
Covid-19 vaccine makers Moderna and BioNTech became household names almost overnight. Moderna and BioNTech have spent their Covid vaccine windfalls differently, with Moderna investing in its own mRNA ...
MAINZ, Germany, October 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced it had commenced its public exchange offer (the “Offer”) for all outstanding shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results